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Abstract
Background: Collagen is a structural protein that provides mechanical stability and defined architectures to skin. In
collagen-based skin disorders this stability is lost, either due to mutations in collagens or in the chaperones
involved in collagen assembly. This leads to chronic wounds, skin fragility, and blistering. Existing approaches to
treat such conditions rely on administration of small molecules to simulate collagen production, like 4-
phenylbutyrate (4-PBA) or growth factors like TGF-β. However, these molecules are not specific for collagen
synthesis, and result in unsolicited side effects. Hsp47 is a collagen-specific chaperone with a major role in collagen
biosynthesis. Expression levels of Hsp47 correlate with collagen deposition. This article explores the stimulation of
collagen deposition by exogenously supplied Hsp47 (collagen specific chaperone) to skin cells, including specific
collagen subtypes quantification.
Results: Here we quantify the collagen deposition level and the types of deposited collagens after Hsp47
stimulation in different in vitro cultures of cells from human skin tissue (fibroblasts NHDF, keratinocytes HaCat and
endothelial cells HDMEC) and mouse fibroblasts (L929 and MEF). We find upregulated deposition of fibrillar
collagen subtypes I, III and V after Hsp47 delivery. Network collagen IV deposition was enhanced in HaCat and
HDMECs, while fibril-associated collagen XII was not affected by the increased intracellular Hsp47 levels. The
deposition levels of fibrillar collagen were cell-dependent i.e. Hsp47-stimulated fibroblasts deposited significantly
higher amount of fibrillar collagen than Hsp47-stimulated HaCat and HDMECs.
Conclusions: A 3-fold enhancement of collagen deposition was observed in fibroblasts upon repeated dosage of
Hsp47 within the first 6 days of culture. Our results provide fundamental understanding towards the idea of using
Hsp47 as therapeutic protein to treat collagen disorders.
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Background
Collagen (COL) fibers represent 60–80% of skin dry
weight and confer skin its resistance to mechanical stress
[1–4]. The skin is a layered tissue, and the collagen com-
position and morphology of each layer is different [5, 6].
COL I is predominant in the dermal and hypodermal
layer, and forms heterotypic structures with other colla-
gens such as COL III and/or V [7]. The basement mem-
brane separating the epidermis and dermis is rich in COL
IV. In multiple skin pathologies collagen organization is
altered, either genetically or acquired due to environmen-
tal factors. Genetic collagen-related skin disorders such as
Epidermolysis bullosa (EB) [8] and Ehlers-Danlos Syn-
drome (EDS) are both caused due to mutations in fibrillar
COL I [9] and/or COL III [10]. The patients have fragile
skin, blisters and chronic wounds as a consequence of
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reduced collagen levels in the skin tissue due to collagen
misfolding, impaired formation of highly organized struc-
tures, poor collagen crosslinking, and accelerated collagen
degradation [11]. Scurvy and Aging have localized wrin-
kles and blisters due to weakening of skin structural archi-
tecture between dermis and epidermis due to sparse
collagen fiber density and extensive degradation of fibrillar
collagen, mostly COL I [12, 13] by matrix metalloprotein-
ase [14, 15]. The existing therapies for these disorders are
based on the delivery of growth factors (e.g. TGF-beta [16,
17]) and chemical stimulants (e.g. ascorbic acid [17–19],
glycolic acid [20], 4-phenyl butyric acid (4-PBA) [21] and
retinol [22]) to boost the collagen production and matrix
deposition. However, these molecules have multiple other
roles in the body and the therapies are associated with
negative side effects, such as promoting abnormal angio-
genesis, or inflammatory responses.
We recently demonstrated that treatment of fibroblast
cultures with exogenous Hsp47 specifically enhances
collagen deposition [23]. Uniquely, Hsp47 is a collagen-
specific chaperone. It has multiple roles in collagen bio-
synthesis, i.e. it stabilizes triple helical of procollagen at
body temperature [24–29], it prevents intracellular pro-
collagen degradation [30–32], it is involved in quality
control of folded procollagen [32, 33], it inhibits procol-
lagen aggregate formation in the Endoplasmic Reticulum
(ER) [34, 35], and it supports procollagen transport to
Golgi apparatus [31] by binding to procollagen in the ER
(at neutral pH) and dissociating in the cis-Golgi (at low
pH). The involvement of endogenous Hsp47 in the bio-
synthesis of collagen subtypes I to V has been reported
[23, 30, 35, 36]. It is however unclear if exogenous ad-
ministration of Hsp47 to cells affects the deposition of
each collagen subtype to a similar level, or if deposition
of certain collagen is preferentially supported. Note that
expression levels of Hsp47 are altered in some variants
of EB [37] and EDS [30] and this protein is up regulated
in cancer [38–40].
Hsp47 is retained in the ER via KDEL receptor medi-
ated transport from the Golgi to the ER [26, 30, 41–45].
This KDEL-receptor is also found on the cell membrane,
[46] and is critical for the uptake of exogenous Hsp47
and transport to the ER of cells by simply adding the
protein to the culture medium [23]. Expression levels of
KDEL receptor at the cell membrane are cell-dependent
[47, 48]. Therefore, Hsp47 uptake and the resulting up
regulated collagen expression levels by exogenous Hsp47
might also be cell-dependent.
In the current work we follow-up on our previous
demonstration of Hsp47-stimulated deposition of colla-
gen in fibroblast cultures [23], and we quantify the cell-
and type-specific collagen deposition (fibrillar collagens
I, III, V, network collagen IV, and fibril-associated colla-
gen XII) after Hsp47 stimulation in cultures of
fibroblasts, epithelial and endothelial cells from skin tis-
sue, from human and mouse (Fig. 1). Lastly, the increase
in the collagen deposition upon repetitive delivery of re-
combinant Hsp47 was also studied. Our results provide
fundamental understanding of the potential of Hsp47 as
therapeutic protein.
Results
The uptake of Hsp47 was tested in human fibroblast
(NHDF from dermis), epithelial (HaCaT, epidermal ker-
atinocytes) and endothelial (HDMEC from dermis) skin
cells. Since knocking out Hsp47 is embryonically lethal,
the only established stable Hsp47 knockout cell-line cur-
rently available is a fibroblast cell line extracted from a
Hsp47 knocked-out mouse embryo [49]. We used this
cell line to test the activity of exogenously supplied H47
to trigger collagen deposition without the influence of
endogenous Hsp47. We also tested other two mouse fi-
broblasts: MEF wild type cells from embryos and L929
(from adipose tissue) as skin fibroblast from adult mice
[50], representing an intermediate model between hu-
man adult skin fibroblasts and MEF cells.
A recombinant EGFP-tagged Hsp47 [23] (hereafter re-
ferred to as H47) was used for these studies. The differ-
ent cell types were seeded at the same cell density and
incubated with H47 at concentrations between 0.1 μM
and 1.0 μM. The incubation time of 3 h was uptaken
from our previous experience [23]. H47 uptake was visu-
alized by epifluorescence imaging of EGFP green signal.
Incubation with H47 concentrations below 0.1 μM
showed no detectable fluorescence signal inside the cells.
Cells incubated with 1 μM or higher H47 showed fluores-
cent aggregates on the surface of the culture plate, indi-
cating that saturation levels of H47 for uptake were
achieved and H47 was binding to extracellular collagen
deposited by the cells (Fig. S1). At the intermediate con-
centrations accumulation of green fluorescence was de-
tected inside the cells and no aggregates were observed
outside the cells, indicating efficient uptake of H47.
Co-localization of H47 and the ER signals confirmed
accumulation of the uptaken H47 at the ER in a cell
types (Fig. 2a, S2). No fluorescence signal was observed
when cells were incubated with EGFP alone, indicating
that uptake is specific to the H47 sequence and not me-
diated by the EGFP label (Fig. S2–3). H47 uptake was
quantified by counting the percentage of cells with de-
tectable ER- and H47 fluorescent signals after incubation
for 3 h and medium change. 100% uptake indicates that
all the cells with labeled ER contained labeled H47. Re-
sults show that H47 uptake was concentration
dependent, and also cell type dependent (Fig. 2b). An in-
crease in the H47 incubation concentration led to in-
creased uptake, and > 80% uptake was observed for
fibroblasts and endothelial cells at 0.5 μM H47.
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Fig. 1 Scheme showing enhanced collagen deposition by treatment with recombinant H47. Immuno-staining of COL I in decellularized matrices
of fibroblast, epithelial and endothelial cell line cultures is shown in Red using COL I antibody. Scale: 250 μm
Fig. 2 a Z-stack fluorescence images showing up taken 0.3 μM H47 (green) co-localized with ER (red) in NHDF (Blue: DAPI). The yellow dotted line
around the cells indicates the edge of the cells. Scale: 20 μm, b H47 uptake by human skin cells (NHDF, HaCaT and HDMEC) and mouse fibroblast
(L929, MEF) cells. Cells were incubated with increasing concentrations of H47 in the medium (0.1 μM–1.0 μM) for 3 h. The % of H47 uptake was
obtained by quantifying the percentage of cells showing H47 (EGFP green signal) and ER tracker dye (Red signal). 100% H47 uptake of cells
indicate that all cells in culture had co-localized signal. Error bars indicate standard deviation of n = 3 experiments. c Western blot of KDEL
receptor in membrane protein fractions of human skin cells and mouse fibroblast cells using KDEL receptor antibody. GAPDH signal indicates
equal cell density in cytosolic fraction of the corresponding cells stained with GAPDH antibody. Quantification data using whisker’s plot shows
deviation in distribution of KDEL receptor in membrane protein fractions. Error bars indicate standard deviation of n = 3 experiments. Statistical
significance was analyzed by Tukey test comparing KDEL receptor signal from different cell types (mean ± SD, ANOVA, *** p < 0.001)
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Saturation levels are achieved at 0.5 and 0.8 μM H47 for
MEF and L929 cells, and at 1 μM H47 for NHDF and
HDMECs. HaCaT cells showed the lowest uptake, with
maximum uptake values of approximately 80% achieved
at > 0.8 μM H47 concentrations.
Our previous work demonstrated that H47 uptake oc-
curs through KDEL receptor mediated endocytosis and
transport [23] In order to check if the differences in up-
take among the different cell types are related to differ-
ences in the density of KDEL receptor on the cell
membrane, the membrane protein fraction from all cell
types was separated and stained with KDEL receptor
antibody. The cytosolic fraction was stained with
GADPH antibody and taken as control for cell density.
The quantified relative intensity of KDEL receptor pro-
tein bands present in membrane fraction correlated with
the amount of uptaken Hsp47 in all cell types (Fig. 2 b,
c). GAPDH bands were of similar intensity (0.05% vari-
ation) in all the samples, indicating similar cell density
(Fig. 2 c). These results demonstrate that Hsp47 uptake
by cells is dependent on KDEL receptor display on the
cell membrane, as suggested in earlier reports [46].
We then compared H47-induced collagen deposition
by the different cell types after incubation with H47.
TGF-β 1 and ascorbate were used as control collagen
stimulants. Cells were seeded for 24 h on tissue culture
plastic wells and incubated with 0.5 μM of H47, 0.5 μM
of TGF-β 1 or ascorbate for 3 h, followed by medium ex-
change and further culture for 24 h. The deposited colla-
gen on the culture plate was labeled with Picro Sirius
Red and quantified by spectrophotometry. Sirius red is a
strong anionic dye comprising six sulfonate groups that
binds preferentially to the cationic groups of the colla-
gen fibers [51, 52]. Data were normalized to the value of
collagen deposition by NHDF cells without any treat-
ment. The human fibroblast cell line NHDF showed a
70% increases in collagen deposition when treated with
H47, whereas the epithelial (HaCaT) and endothelial
(HDMEC) cell lines showed 20 and 50% increase re-
spectively. Interestingly, under the same conditions, fi-
broblasts from mouse origin (MEF and L929) also
showed 70–100% increase in fibrillar collagen depos-
ition. These data indicate that exogenously supplied H47
induces more effective collagen deposition in fibroblast
cells. This is in agreement with the natural role of fibro-
blasts as major matrix-producing cells in connective tis-
sue [53, 54]. An increase in collagen deposition was also
observed in all cell types treated with TGF-β 1 and as-
corbate (Fig. 3a). However, H47 treatment induced 20–
50% higher increase in collagen deposition than the con-
trols (Fig. 3a).
Next, we followed collagen deposition after H47 expos-
ure at increasing culture times up to 14 days. Collagen
deposition in fibroblasts (NHDF, MEF and L929)
without H47 treatment increased during the first 6 days
and reached a steady state at longer time scales (Fig. 3 b,
S4). This trend correlates with proliferation kinetics ex-
pected for this cells, and the expected down regulation
of matrix production when confluency is reached [55].
Fibroblast cells were 80–100% confluent at day 9–10.
HaCaT and HDMEC cells did not show an appreciable
increase in collagen deposition with time, and the overall
amount of deposited collagen was much lower (Fig. 3 c,
d). When cultures were treated with H47 on day 1, the
total amount of deposited collagen doubled on day 1, at
least, but the collagen deposition profile at longer times
did not change significantly, i.e. the curve was just
shifted to higher collagen values from day 1 (Fig. 3 b-d,
S4). This result is in agreement with the expected life
time of H47 (more than 24 h for natural Hsp47 at
physiological conditions [23, 56]). These results also in-
dicate that the deposited collagen after H47 treatment
has a similar stability to the naturally deposited collagen
without H47 stimulation.
We then tested if the amount of deposited collagen
could be further increased by repetitive delivery of H47
on consecutive days. Culture medium was supplemented
with 0.5 μm H47 on days 1, 3, 6, 9 and 12, and collagen
deposition was quantified on days 1, 3, 5, 7, 10 and 14.
A 2–3 fold increase in collagen deposition was observed
in NHDF, MEF and L929 cells after repeated treatment
with H47 until day 5. HaCaT and HDMEC cells showed
1–1.5 fold increase in collagen deposition within the
same timescale. Addition of H47 on days 6, 9 and 12 did
not result in further changes in the deposited amount of
collagen (Fig. 3b-d, S4). This plateau of collagen depos-
ition also occurred in the control experiments, in which
cells were not treated with H47 within the same period
of time, and is again associated with the achievement of
confluency in the 2D cell culture. Confluency results in
cell senescence, up-regulation of MMPs 40% (especially
MMP1, 52%) and down regulation of MMP inhibitors
and ECM proteins like collagens and elastin at genetic
levels (approximately 4 times less) [57–60]. In order to
confirm this hypothesis, H47 treatment was performed
on 2D L929 cell cultures once they reached confluence
(Day 10). No significant increase in collagen deposition
was observed 24 h after this treatment (Fig. S5a), corrob-
orating our hypothesis. In addition, H47 was found
bound to matrix collagen on the culture substrate, with
no detectable delivery inside the cells (Fig. S5b). In sum-
mary, repeated dosage of Hsp47 increased collagen pro-
duction in 2D cultures of skin cells until cells reached
confluency.
TGF-β and other inducers have been reported to trig-
ger differentiation of dermal fibroblast to myofibroblast
during scar formation [61, 62]. TGF-β1-induced myofi-
broblast differentiation through the Smad2/3 signaling
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pathway increases Hsp47 expression levels [63]. To ver-
ify if exogenous supply of H47 treatment also induced
such transformation, NHDF cells were treated with both
collagen stimulators and immunostained with myofibro-
blast transformation marker (α-SMA (α = Smooth
Muscle Actin)). NHDF cultures were incubated with
0.5 μM of H47 and TGF-β 1 for 3 h, followed by medium
exchange and 24 h cultivation. Cells were then fixed and
stained with α-SMA. NHDFs treated with TGF-β 1
showed α-SMA signal, indicating myofibroblast trans-
formation. Conversely, no α-SMA signal was observed
on H47 treatment in NHDF cells (Fig. S6). This indicates
exogenously supplied Hsp47 in controlled amount
cannot trigger such side effects. These results confirm
the higher specificity of the H47 protein towards indu-
cible collagen deposition vs. the treatment with the
growth factor, which is currently used in therapeutic
treatments.
The composition of the collagen matrix is tissue-
dependent, and different cells are expected to produce
different collagen types. We investigated if Hsp47-
induced collagen deposited in the cell culture had the
same composition as the naturally secreted collagen in
the different cell types. For this purpose, H47-treated cul-
tures were decellularized and the remaining matrix layer
on the culture plate was stained using antibodies specific
Fig. 3 a Quantification of collagen deposition using Sirius Red assay in different cell types 24 h after 0.5 μM H47 treatment. TGF-β 1 (TGF-β) and
ascorbate of same concentration are used as controls. The plots were normalized to collagen deposition in untreated NHDF. Statistical
significance for both b and c was analyzed by Tukey test comparing untreated against TGF-β, ascorbate and H47 treated cells (mean ± SD,
ANOVA, *** p < 0.001). Error bars representing standard deviation of 6 independent experiments. b-d Quantification of collagen deposition using
Picro Sirius Red assay in b. NHDF, c. HaCat and d. HDMEC cells on days 1,3,5,7,10 and 14. Error bars represent standard deviation from 3
individual experiments
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for COL I, III, IV, V and XII. These collagens were se-
lected based on their abundance in skin tissue and their
involvement in skin related disorders, in which they are
reduced or mutated [9–11, 22, 54]. The relative abun-
dance of each collagen subtype was obtained from fluor-
escence imaging of the culture plate. The mean
fluorescence intensity value for each collagen subtype
was corrected by subtraction of the background (see ex-
perimental details), and normalized by the correspond-
ing value obtained in untreated NHDF cells. An increase
in the deposition of fibrillar COLs I, III and V was ob-
served in all cell types upon H47 treatment. The increase
in the deposition of fibrillar collagens I, III and V was
significantly higher in fibroblast cultures vs. HaCaT and
HDMEC cultures. Conversely, deposition of network
COL IV upon H47 treatment was only enhanced on
HaCaT and HDMECs (Fig. 4 and S7). No changes were
observed in the deposition of COL XII, suggesting that
Hsp47 may not be involved in the secretion of the fibril-
associated COL XII (Fig. 4b). We observed that cell
spreading increased in cultures treated with Hsp47,
which is an expected finding as collagen is a matrix pro-
tein with multiple adhesion sites for the integrin family.
We also studied the influence of exogenously supplied
H47 on collagen production in a previously established
MEF Hsp47-knockout fibroblast cell line (Hsp47−/−),
which does not produce endogenous Hsp47 [49, 64, 65].
Deposition of fibrillar COLs I, III and V increased upon
H47 treatment. No increase in COL IV and XII was ob-
served, in agreement with previous observations in the
other fibroblast cell lines (Fig. 5 a-b, S8). In order to
quantify deposited collagen subtypes at higher sensitiv-
ity, western blot analysis of the deposited matrix was
performed. Higher deposition of COL I, III and V was
confirmed, and a very low amount of COL IV was also
detected. Interestingly, similar analysis performed with
healthy MEF cells (Hsp47+/+) revealed that these cells
produced these collagen types to similar extent as ob-
served in Hsp47−/− cells after H47-induction (Fig. 5c).
These results demonstrate that treatment of H47 defi-
cient cells with exogenous H47 restores the ability of the
cells to deposit collagen at levels and composition simi-
lar to healthy cells. Taking into account the physiological
relevance of matrix composition and properties in cellu-
lar behavior in vivo we speculate that treatment with
Hsp47 could be a useful approach to enhance collagen
synthesis and matrix deposition on-demand.
Discussion
Hsp47 is a collagen-specific chaperone protein with mul-
tiple roles in collagen biosynthesis. Expression levels of
Hsp47 correlate with collagen production [64, 66].
Hsp47 has a regulatory role during scar formation in
neonatal mouse skin after injury, which indicates that its
expression during healing is up regulated in situ, in re-
sponse to injury [67]. These facts indicate that Hsp47
could be an interesting therapeutic target in collagen-
related skin disorders, as alternative to non-specific col-
lagen inducers such as TGF β [68], VEGF [69] or ascor-
bic acid [17, 18]. Therapeutic use of these molecules to
enhance collagen deposition influences other cellular
functions such as proliferation [17, 18, 70, 71], differenti-
ation [70] and angiogenesis [72], leading to undesired
side effects. For example, ascorbate increases collagen
production by acting as a co-factor to proline and lysine
hydroxylases, which are involved in the hydroxylation of
procollagen [42]. However, these enzymes are also in-
volved in the hydroxylation of other matrix proteins, like
Elastin or Fibronectin [73]. In contrast, the unique
collagen-specificity of Hsp47, demonstrated in the litera-
ture [23, 30, 51], would allow up regulation of collagen
deposition, without affecting any other molecule or cel-
lular pathway.
The deposition of fibrillar collagens I and II, and to a
less extent fibrillar collagen V was mainly enhanced in
all tested cell types. Deposition of network COL IV was
only observed in cells that are naturally connected to a
basement membrane, where COL IV is also a major
component. Fibril-associated COL XII was not enhanced
by H47 treatment. The significant enhancement of fibril-
lar collagen deposition vs. other collagen types highlights
the supporting role of Hsp47 in the intracellular assem-
bly, stabilization and transport of collagen superstruc-
tures. A fibrillar collagen specific stimulation of collagen
production could be a positive aspect for a potential
Hsp47-derived therapy to enhance natural collagen pro-
duction in diseases.
It is interesting to compare the efficiency of Hsp47-
based enhancement in collagen deposition vs. treat-
ment with other collagen inducers from literature
data. In the comparison both the amount of deposited
collagen and the time scale at which noticeable de-
position occurred is relevant. We anticipate that the
comparison is done among different cell types and
culture methods and, therefore, numbers can only be
taken as indicative. In our data, the deposition of fi-
brillar COLs I and III in fibroblasts (MEF, L929 or
NHDF) was enhanced up to 70–100% in 24 h. In con-
trast, ascorbate treatment of primary healthy skin
fibroblast increased collagen production by 20–40%
after 4 days of treatment in vitro (measured by radio-
actively labeling procollagen), [74] and only 10% in
Hsp47 deficient fibroblast (measured by Sirus red
assay) [23]. Glycolic acid treatment increased collagen
production by 48% in a week in human skin fibro-
blast culture from neonatal foreskin and outgrown
cells [75] and Vitamin A (retinol) induced a 100% in-
crease in chronological aging skin in human patients
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in vivo after 24 weeks [76]. This comparison reveals
that Hsp47 promotes fast and efficient deposition of
fibrillar collagen in comparison with the other mole-
cules, which would be a beneficial feature for a thera-
peutic use of Hsp47.
In vivo collagen assembles into high order structures
[77]. In 2D cultures the interaction of the secreted colla-
gen with the polystyrene plate affects the assembly [78].
Studies in real tissues would be necessary to proof if the
secreted collagen upon Hsp47 treatment is able to form
morphologically complex structures as it occurs in the
natural extracellular matrix.
Conclusions
The collagen subtype distribution in natural tissue plays
a crucial role in tissue biomechanics, and alterations re-
sult in pathological states. In the skin, alterations in col-
lagen levels are present in EDS, EB or Scurvy, and lead
to chronic wounds, blisters and skin fragility. Our results
show that exogenous delivery of Hsp47 chaperone can
enhance collagen deposition in a cell-specific manner.
Being a collagen specific molecular chaperone, Hsp47
treatment is not expected to affect other cellular process,
unlike other collagen-stimulators like ascorbic acid, gly-
colic acid, retinol or growth factors would do. This is a
Fig. 4 Quantification of H47 stimulated deposition of different collagen subtypes. a. Fluorescence images showing immunostained COL I, III, IV, V
and XII in NHDF cells before and after treatment with 0.5 μM H47 (Scale – 250 μm) b. Quantification of deposited COL I, III, IV, V and XII from
immuno-stained images in NHDF, L929, MEF, HaCaT and HDMEC cultures. Data correspond to collagen deposition 24 h after H47 treatment and
controls. The plots were normalized with MEF cells untreated condition as 1. Error bars represent standard deviation from n-3 experiments.
Statistical significance was analyzed by Tukey test comparing non treated against H47 treated cells (mean ± SD, ANOVA, *** p < 0.001)
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relevant advantage of Hsp47 for its potential use as
matrix-stimulating therapeutic protein.
Methods
Synthesis and purification of H47
EGFP-Hsp47 (H47) was synthesized and purified using
previously established protocol [23]. Pre-inoculums of
H47 were grown overnight in LB medium containing
NaCl (5 g/L) and kanamycin (Kan) (25 μg/ml) at 37 °C/
250 rpm. After 24 h, the cultures were transferred into a
2 L flask and were grown until OD600 of 0.65 in 1 L LB
NaCl Kan media at 37 °C/250 rpm for proper aeration.
The protein expression was induced with 1.0 mM
isopropyl-β-d-thio-galactoside and was incubated over-
night at 30 °C/180 rpm. The cultured cells were har-
vested and pellets were stored at − 80 °C. Stored cells
thawed and were resuspended in lysis buffer (300 mM
NaCl, 10 mM imidazole, 20 mM Tris, pH 8) and lysed by
sonication. Cleared lysate was purified by Ni-NTA affin-
ity chromatography (Ni-NTA superflow; Qiagen). The
soluble fraction was concentrated and purified further
by 50 K Advanced Centrifugal Device (Macrosep) in
Fig. 5 a. Quantification of fibrillar collagen deposited in MEF Hsp47−/− and Hsp47 +/+cells (control) at 24 h after H47 treatment (0.5 μM) using
Sirius Red assay. b. Quantification of deposited COL I, III, IV, V and XII from immuno staining assays in MEF Hsp47−/− cultures. Error bars
representing standard deviation from n-3 experiments in a and c, The plots in both a and c assays were normalized by MEF Hsp47−/− cells
untreated condition taken as 1. Statistical significance in a and c was analyzed by Tukey test. Significance was calculated by comparing non
treated against Hsp47 treated cells (mean ± SD, ANOVA, *** p < 0.001). c. Western blot of COL I, III, IV, V and XII in deposited collagen from MEF
Hsp47 +/+, Hsp47 −/− and Hsp47−/− cultures 24 h after treatment with 0.5 μM H47. Equal amount of cells were analyzed. Black bands indicate
signal from collagen subtypes specific antibody. The wiskers plot indicates relative gel bands intensity of different collagen types in MEF Hsp47
+/+, Hsp47 −/− and Hsp47−/− H47 treated conditions. Error bar indicates standard deviation from n-3 experiments. Statistical significance was
analyzed by Tukey test. Significance was calculated by comparing non treated Hsp47 −/− against Hsp47 treated cells (mean ± SD,
ANOVA, *** p < 0.001)
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buffer A [20 mM Hepes (pH 7.5), 300mM NaCl, and 4
mM DTT].
Cell culture and quantification of H47 uptake
Hsp47+/+ and Hsp47−/− MEFs derived from Lethal
Mouse Embryos [49] were gifted by Prof. Dr. Kazuhiro
Nagata, Kyoto Sangyo University, Japan, L929 fibroblasts
(ATCC CRL-6364), NHDF (Promo Cell C-12302),
HaCaT (ATCC® PCS-200-011) and HDMEC (Promo
Cell C-12210) were purchased from commercial
suppliers.
MEF, L929, NHDF and HaCaT cells were seeded on
15 well Ibidi μ-Slide Angiogenesis plates (20,000 cells
per well) with DMEM GlutaMax (Gibco) containing 10%
fetal bovine serum (FBS; Gibco) and 1% Penicillin-
Streptomycin (Pen-strep) antibiotic. HDMEC cells (20,
000 cells per well) were seeded using M199 medium
with endothelial growth supplement (Gibco), 10% fetal
bovine serum (FBS; Gibco) and Pen-strep antibiotic.
After 24 h, cells were incubated for 3 h with varying con-
centrations of H47 (0.1 μM–1 μM). The medium was re-
moved and cells were washed once with sterile Assay
buffer (1X) provided in the kit. A dual staining solution
(for nucleus and ER) was prepared by mixing 1 μl of ER
tracker dye (ER Staining Kit - Red Fluorescence - Cyto-
painter (ab139482)) with 1 μl of DAPI in 1 ml of ER
Assay buffer (1X) provided in the kit. The cells were in-
cubated with 60 μl of Dual staining solution per well at
37 °C for 1 h. Cells were washed with Assay buffer (1X)
once, fixed with 4% PFA for 10 mins and washed three
times with Assay buffer (1X). All the experiments were
done in triplicate.
Cell cultures were imaged using a Nikon Ti-Ecllipse
microscope (Nikon Instruments Europe B.V., Germany)
with a 60X objective. The number of cells showing both
H47 signal with ER tracker signal were counted and rep-
resented in percentage. Image J was used for the ana-
lysis. Graphs were plotted using graph prism software
for three independent experiments for each cell type and
10 images each.
Quantification of KDEL receptor at the cell surface by
western blotting
To quantify the density of KDEL receptor on the cell
membrane a western blot analysis was performed. 2.5
million cells (NHDF, Hacat, HDMEC, MEF and L929)
cells were used to extract membrane protein and cyto-
solic protein fraction using the Mem-PER™ Plus Mem-
brane Protein Extraction Kit (Thermo, 89,842) following
manufacturers protocol. The extracted protein fractions
we mixed with 4x Lameli buffer and heated at 95 °C for
10 mins for denaturation. 15 μL of protein fractions were
loaded on 12% SDS PAGE gels along with the marker.
The gels were transferred to PVDF membranes using
the blotting chamber. The blotted PVDF Membranes
were blocked with Blocking buffer (0.5% milk powder in
PBST (0.1 w/v)) for 20 min. The excess blocking buffer
was washed off three times using PBST. The membrane
fraction PVDF membranes were incubated for 1 h with
anti-mouse KDEL receptor monoclonal primary anti-
body (KR-10) (Enzo life sciences, ADI-VAA-PT048-D)
and cytosolic fraction with anti-rabbit GAPDH (14C10)
Rabbit mAb primary antibody (Cell signaling, 2118S).
Excess antibody was washed off three times using PBST
(0.5 w/v) and the sample was stained with secondary
antibody for 20 min at room temperature (For mem-
brane fraction: Goat anti-Mouse IgG (H + L) Highly
Cross-Adsorbed Secondary Antibody, Alexa Fluor 546,
A-11030,Thermo fisher (1:500 dilution). For cytosolic
fraction: (Goat anti-Rabbit IgG (H + L) Highly Cross-
Adsorbed Secondary Antibody, Alexa Fluor 647, A-
21245, Thermo fisher (1:500 dilution)). The PVDF mem-
brane after staining was visualized under Gel Doc. All
the experiments were done in triplicate. Image J software
was used to quantify KDEL receptor signal with each
band for corresponding cells and data was normalized to
highest value of NHDF intensity as 1.
Sirus red assay for quantification of collagen deposition
after stimulation
Cells were cultured in 24 well plate for 24 h (50 K(50,000)
cells per well) and then incubated with 0.5 μM solutions
of H47 in DMEM and M199 medium for 3 h, followed by
medium exchange and cultured for 1, 3, 5, 7, 10 and 14
days. Non treated cells were cultured for similar time
points and used as controls in this experiment. For testing
repeated H47 treatments in all the cell types, H47 was also
added on day 1, 3, 6, 9 and 12. Collagen deposition was
quantified on days 1, 3, 5, 7, 10 and 14. For the control ex-
periments with ascorbate and TGFβ1, cells were cultured
in 24 well plate and incubated with 0.5 μM ascorbic acid
phosphate (Ascorbate) (Sigma, A8960-5G,L-Ascorbic acid
2-phosphate sesquimagnesium salt hydrate) and 0.5 μM
TGFβ1 (Recombinant Human TGF-beta 1 Protein, 240-B-
010, R & D systems) for 3 h, followed by medium ex-
change and cultured for 24 h.
For Sirius Red assay, cells were fixed using Bouin solu-
tion (75% picric acid, 10% formalin, and 5% acetic acid)
(Sigma HT10132). Collagen deposited in the wells was
stained by incubating with 0.1% Sirius red in picric acid
(ab150681) for 1 h and washing with 0.01 N HCl. The
matrix was dissolved in 0.1 N NaOH and the absorption
of the slurry were measured at 570 nm using a Biolu-
min960k spectrophotometer [23, 51]. The absorbance
values (Fig. 3a in manuscript) were normalized by the
value of collagen deposition from untreated NHDF cells
in 24 h. In MEF Hsp47 −/− untreated cells were consid-
ered as 1 for Fig. 5a.
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For testing ability of H47 to enhance collagen depos-
ition on cells reaching confluency, L929 were seeded at a
high density (50,000 cells/ well) and allowed to become
confluent within 2 days and treated with H47 and kept
for 24 h after treatment. Collagen deposition was quanti-
fied using sirus red assay as described above. The ab-
sorbance values were normalized by the value of
collagen deposition from untreated L929 cells in 24 h as
1. Also deposited collagen was stained with COL 1 anti-
body with the protocol mentioned below.
Myofibroblast differentiation assay
For testing myofibroblast differentiation of NHDF cells
on TGFβ and H47, 25,000 cells/ well were first cultured
for 24 h with DMEM medium, 10% FBS and antibiotics.
After this cells were supplemented with 0.5 μM of
TGFβ1 (Recombinant Human TGF-beta 1 Protein, 240-
B-010, R & D systems) or H47 in the medium. After 3 h
medium was exchanged by normal medium, and cells
were incubated for further 24 h. Cells were fixed with 4%
PFA and stained with Anti-alpha smooth muscle Actin
primary antibody (Abcam, ab5694) for 1 h at RT. Cells
were washed three times with PBS and incubated with
goat anti-Rabbit IgG (H + L) Highly Cross-Adsorbed
Secondary Antibody, Alexa Fluor 647, Thermofischer A-
21245 and DAPI (1:5000). For both primary and second-
ary antibodies 1:200 was used. Microscopic imaging was
performed using with Nikon Ti-Eclipse microscope. All
the experiments were done in triplicates.
Immunostaining of collagen subtypes
For immunostaining the different collagen subtypes, the
cultures were first decellularized using a previously
established protocol [79], fixed and immunostained with
collagen-specific antibodies. Cultures were treated with
0.5% Triton X-100 and 20 mM NH4OH for 5 min at
37 °C for decellularization, and then fixed with 4% PFA.
The remaining matrix on the culture substrate was
blocked with 5% goat serum in PBS and stained for COL
I, III, IV, V and XII with primary antibodies as recom-
mended by supplier (Rabbit polyclonal anti-type I
collagen, 600–401–103-0.1 (Rockland), Collagen III
Polyclonal Antibody (Thermo fisher, PA5–34787), Anti-
COL4A3 antibody (Sigma, HPA042064-100UL), Anti-
Collagen V antibody (ab7046), Anti-COL12A1 antibody
(Sigma, HPA070695) (dilution 1:200 for all the anti-
bodies)). Samples were washed 3 times with PBS and
stained with secondary antibody (goat anti-Rabbit IgG
(H + L) Highly Cross-Adsorbed Secondary Antibody,
Alexa Fluor 647, A-21245 (dilution 1:200)). For analysis,
the mean gray value of fluorescence intensity was mea-
sured for each collagen subtypes and subtracted from
background mean gray value of fluorescence intensity by
imaging stained collagen with only secondary antibody.
Results were normalized by taking untreated MEF cells
as 1. In MEF Hsp47 −/− untreated cells were considered
as 1. This analysis was performed in Image J. Ten images
from each condition were used for the analysis from
three independent experiments.
Quantification of collagen subtypes by western blotting
for MEF Hsp47 −/−
For quantification of the collagen subtypes after H47
treatment, MEF Hsp47 −/− cells 50,000 cells were used
as equal seeding density in all cell types. Deposited colla-
gen from cells cultured in the presence and in the ab-
sence of H47 was suspended in 300 μL of RIPA Buffer.
Before this step, the collagen deposited was decellular-
ized using the above-mentioned protocol. Protease in-
hibitor and Lameli buffer (4x stock concentration) was
added in mixture to avoid protein degradation. The sam-
ples were loaded into SDS-PAGE gels. The 12% SDS
PAGE gels were transferred using blotting chamber to
PVDF membranes. The Blotted PVDF Membranes were
blocked with Blocking buffer (0.5% milk powder in PBST
(0.1 w/v)) for 20 mins. The excess blocking buffer was
washed off three times using PBST. The PVDF mem-
branes were incubated overnight at 4 °C with collagen
subtypes antibodies mentioned above. For α-Smooth
Muscle (α-SMA) condition cells were not decellularized
and antibodies used were Anti-Actin, α-Smooth Muscle
- Cy3 (C6198). On the following day the excess was
washed off three times using PBST (0.5 w/v) and the
sample was stained with secondary antibody for 1 h at
room temperature (Goat anti-Rabbit IgG (H + L) Highly
Cross-Adsorbed Secondary Antibody, Alexa Fluor 647,
A-21245 (1:500 dilution). The PVDF membrane after
staining was visualized under Gel Doc. All the experi-
ments were done in triplicate.
Statistical significance
For Sirus Red assay (n = 6) number of experiment were
performed and plotted with graphs including whisker
plots representing standard deviation for MEF, L929,
NHDF, HTCAT and HDMEC. For MEF Hsp47 −/−
three independent experiments were performed. For im-
munostaining quantification IMAGE J was used to quan-
tify mean intensity profile of stained matrices in all cell
types treated with and without H47 with bar plots in-
cluding error bars indicating standard deviation. In both
assays the data were normalized with respect to collagen
deposited in MEF untreated as 1. In case of MEF Hsp47
−/− untreated cells were considered as 1. Statistical sig-
nificance was analyzed by Tukey test, which shows sig-
nificant differences between conditions. Significance was
calculated by comparing non treated vs treated cells
(mean ± SD, ANOVA, *** p < 0.001).
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